Superior cell culture device for more efficient biological production
Award amount
$113,520Program and phase
SBIR · Phase IAward year
2010Award details
- Awarding agency
- Department of Health and Human Services
- Branch
- National Institutes of Health
- Recipient company
- WILSON WOLF MANUFACTURING CORPORATION
- Proposal award date
- Not reported
- Contract end date
- Not reported
- UEI
- L1HKPVNJ33J8
- Solicitation number
- PHS2010-2
- Topic code
- NIGMS
Research abstract
Technology keywords
Not reported
Other awards by this recipient
Verified by the same UEI. These are other public SBIR/STTR award pages, not a merged company record.
- Manufacturing advances to place a powerful form of T cell therapy on the road to commercialization
- Overcoming the last barrier to commercialization of virus-specific T cell therapy
- Moving TIL Therapy Past the Valley of Death
- Islet culture, shipping, and infusion device
- Highly efficient gas permeable cell culture devices
Awards with the same topic code
Verified by an exact topic code match. This is not a text-similarity match.
- Three-Dimensional Spatio-Temporal Control of Lipid Nanoparticle Manufacturing for Improved Nucleic Acid Delivery
- Paradigm-changing, versatile, scalable and cost-effective technology for monthly injections of peptide drugs
- Project MATCH: Multi-spectral AI/ML powered Burn and Wound Evaluation Technology using a Cost-Effective Handheld Device.
- A versatile platform to isolate cells from three-dimensional samples after spatial and temporal profiling
- Development of an Educational Product for Accelerating Solutions for Commercialization and Entrepreneurial Development (ASCEND) in Western IDeA States
Research funding history
11 SBIR/STTR records share this UEI (1999–2017). Reported award amounts total $11,573,014. Reported amounts are not federal obligations.
Phases: Phase II, Phase I, Phase II – Direct to Phase II
Agencies: Department of Health and Human Services